세계의 효소 결합 면역흡착 측정법 시장 : 검사 유형별, 용도별 예측(2025-2030년)

The Enzyme-linked Immunosorbent Assay Testing Market was valued at USD 516.39 million in 2023, expected to reach USD 552.58 million in 2024, and is projected to grow at a CAGR of 7.10%, to USD 834.77 million by 2030.

The enzyme-linked immunosorbent assay (ELISA) testing market pertains to technologies used for detecting and quantifying substances such as proteins, hormones, antibodies, and antigens. ELISA's importance stems from its precision, ease of use, and ability to be automated for high-throughput screening, making it essential in diagnostics, pharmaceuticals, and food industry applications. In diagnostics, ELISA is used for disease diagnosis, including infections and chronic conditions; in pharmaceuticals, for drug and vaccine development; and in the food industry, for detecting allergens and contaminants. The market is growing due to increasing incidences of chronic diseases, advancements in research, a rise in demand for cost-effective diagnostic tools, and expansion in the biotechnology and pharmaceutical industries. Key growth factors include technological advancements like microplate automation and innovations in assay formats which enhance testing capabilities. Moreover, the rising demand for point-of-care diagnostics provides potential opportunities for market players to develop rapid assay solutions.

However, the market faces limitations such as the high cost of testing, the need for skilled professionals, and regulatory constraints which can hinder growth. Challenges also arise from the complex nature of testing procedures and the potential for cross-reactivity, reducing reliability in some applications. Innovating in multiplexing capabilities to allow simultaneous detection of multiple analytes is a promising area for research and business growth. Additionally, improving assay sensitivity and specificity presents opportunities to enhance market penetration. The market demands constant innovation to stay ahead of competitive pressures, with increasing integration of digital and automated solutions likely to shape future developments. Overall, the ELISA market is dynamic and competitive, requiring firms to focus on technological innovation and customer-centric solutions to capture emerging opportunities and address existing challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enzyme-linked Immunosorbent Assay Testing Market

The Enzyme-linked Immunosorbent Assay Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence rate of infectious diseases
  • Need for cost-effective diagnostic tools
  • Government support in increasing infrastructure and treatment initiatives
• Market Restraints
  • Lack of infrastructural faciltities
• Market Opportunities
  • Ongoing developments and launches of the ELISA testing
  • Potential growth for low-cost portable ELISA reader based on image analysis
• Market Challenges
  • Complex assay development workflows

Porter's Five Forces: A Strategic Tool for Navigating the Enzyme-linked Immunosorbent Assay Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enzyme-linked Immunosorbent Assay Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enzyme-linked Immunosorbent Assay Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enzyme-linked Immunosorbent Assay Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enzyme-linked Immunosorbent Assay Testing Market

A detailed market share analysis in the Enzyme-linked Immunosorbent Assay Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enzyme-linked Immunosorbent Assay Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enzyme-linked Immunosorbent Assay Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enzyme-linked Immunosorbent Assay Testing Market

A strategic analysis of the Enzyme-linked Immunosorbent Assay Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enzyme-linked Immunosorbent Assay Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam, Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne Corporation, bioMerieux, Inc., Enzo Life Sciences, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Merck KGaA, PerkinElmer, RayBiotech Life Inc., Shenzhen YHLO Biotech Co., Ltd., Thermo Fisher Scientific. Inc., and ZEUS Scientific, Inc. by Sebia.

Market Segmentation & Coverage

This research report categorizes the Enzyme-linked Immunosorbent Assay Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test Type, market is studied across Competitive ELISA, Indirect ELISA, Multiple & Portable ELISA, and Sandwich ELISA.
• Based on Application, market is studied across Cancer, Immunology, Infectious Diseases, Inflammation, and Protein Quantitation.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence rate of infectious diseases
    • 5.1.1.2. Need for cost-effective diagnostic tools
    • 5.1.1.3. Government support in increasing infrastructure and treatment initiatives
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of infrastructural faciltities
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing developments and launches of the ELISA testing
    • 5.1.3.2. Potential growth for low-cost portable ELISA reader based on image analysis
  • 5.1.4. Challenges
    • 5.1.4.1. Complex assay development workflows
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Enzyme-linked Immunosorbent Assay Testing Market, by Test Type

• 6.1. Introduction
• 6.2. Competitive ELISA
• 6.3. Indirect ELISA
• 6.4. Multiple & Portable ELISA
• 6.5. Sandwich ELISA

7. Enzyme-linked Immunosorbent Assay Testing Market, by Application

• 7.1. Introduction
• 7.2. Cancer
• 7.3. Immunology
• 7.4. Infectious Diseases
• 7.5. Inflammation
• 7.6. Protein Quantitation

8. Americas Enzyme-linked Immunosorbent Assay Testing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Enzyme-linked Immunosorbent Assay Testing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Enzyme-linked Immunosorbent Assay Testing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam
• 2. Agilent Technologies Inc.
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories
• 5. Bio-Techne Corporation
• 6. bioMerieux, Inc.
• 7. Enzo Life Sciences, Inc.
• 8. Eurofins Scientific SE
• 9. F. Hoffmann-La Roche AG
• 10. Merck KGaA
• 11. PerkinElmer
• 12. RayBiotech Life Inc.
• 13. Shenzhen YHLO Biotech Co., Ltd.
• 14. Thermo Fisher Scientific. Inc.
• 15. ZEUS Scientific, Inc. by Sebia